The Brazilian company is a global leader in animal protein-based products and entered the health and nutraceuticals market with the launch of Genu-in. Investments in the new plant totaled BRL 400 million (about USD 78,1 million).
LATEST NEWS
- Brazil’s Ambipar opens offices in Dubai, Abu Dhabi
- Saudi Arabia opens yerba mate market to Brazil
- Brazil export: Interest rate equalization prepaid
- Algeria to expand agricultural financing in 2025
- Brazil re-enters UNESCO alliance
- Climate events could affect Mauritania’s economy
- Saudi art exhibition in Rio offers poetic journey
- Morocco’s women rug weavers save age-old craft
